Korro Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2017
Net Income	-81.19	-81.17	-58.03	-84.69	-26.51	-19.8	Upgrade
Depreciation & Amortization	7.54	7.24	3.91	3.84	1.58	0.81	Upgrade
Share-Based Compensation	-0.19	2.38	1.14	21.75	9.98	3.61	Upgrade
Other Operating Activities	-1.21	4.27	-0.66	-16.96	-30.24	48.54	Upgrade
Operating Cash Flow	-75.04	-67.28	-53.65	-76.06	-45.19	34.22	Upgrade
Capital Expenditures	-13.35	-7.84	-5.21	-2.91	-6.67	-1.06	Upgrade
Change in Investments	13.41	19	16.27	-63.21	17.07	-17.2	Upgrade
Investing Cash Flow	0.05	11.16	11.06	-66.13	10.4	-18.26	Upgrade
Share Issuance / Repurchase	154.66	154.55	0.06	1.36	41.69	80.06	Upgrade
Debt Issued / Paid	2.5	0	0	0	15	0	Upgrade
Other Financing Activities	33.21	33.21	-0.04	-	-	61.95	Upgrade
Financing Cash Flow	190.37	187.76	0.02	1.36	56.69	142.02	Upgrade
Net Cash Flow	115.38	131.64	-42.57	-140.83	21.9	157.97	Upgrade
Free Cash Flow	-88.4	-75.12	-58.86	-78.97	-51.86	33.15	Upgrade
Free Cash Flow Margin	-	-	-	-561.37%	-140.22%	114.53%	Upgrade
Free Cash Flow Per Share	-11.02	-49.12	-230.65	-114.95	-80.39	191.65	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).